| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |